<?xml version="1.0" encoding="UTF-8"?>
<p id="Par106">While inovio works on DNA vaccine, Moderna Therapeutics, Curevac, and Shanghai East Hospital (Tongji University)—Stermirna Therapeutics, are exploring RNA vaccine platforms. The information available to the public indicates that Moderna is using the Messenger RNA vaccine while two latter are working on mRNA technology. Moderna has a few months to start clinical trials, but much longer is needed so it would be ready for full testing. Others are in the preclinical phase [
 <xref ref-type="bibr" rid="CR117">117</xref>–
 <xref ref-type="bibr" rid="CR119">119</xref>].
</p>
